Heeyoung Kim

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah et al. · Cell Reports · 2021 · 117 citations · Full text

Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation

Woan-Ing Twu, Ji‐Young Lee, Heeyoung Kim et al. · Cell Reports · 2021 · 101 citations · Full text

Viral Replication, Viral Polymerase Mechanism, Viral Pathogenesis +16

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19

Kas Steuten, Heeyoung Kim, John C. Widen et al. · ACS Infectious Diseases · 2021 · 100 citations · Full text

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients

Louise Benning, Christian Morath, Marie Bartenschlager et al. · American Journal of Transplantation · 2022 · 48 citations · Full text

In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes

Mahmoud ElHefnawi, Tae Kyu Kim, Mona Kamar et al. · PLoS ONE · 2016 · 46 citations · Full text

Experimental Validation, Synthetic Virology, Molecular Biology +20